MTPA's oral therapy Radicava (edaravone) has shown decreased functional decline and improved survival in long-term ALS trials ...

Neurizon Therapeutics has reported positive topline results from an open-label extension (OLE) study of its lead candidate ...

DelveInsight's HDAC Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast report includes a ...

Jodi O’Donnell-Ames founded Hope Loves Company to provide support, resources, and community to children affected by ALS.

Summary: A new study has uncovered why some motor neurons resist degeneration in ALS while others succumb. Researchers found ...

The latest update is out from Neurosense Therapeutics Ltd. ( ($NRSN) ). As of August 20, 2025, NeuroSense Therapeutics Ltd. reported that ...

Since 2023, the Inflation Reduction Act (IRA) has capped the cost of insulin for Medicare beneficiaries at $35 per month.

The ketamine product KETARx made by PharmaTher has been approved by the FDA for use in surgical pain management.

A strong performance from APA’s gas transmission and storage business contributed to a 6.4% lift in EBITDA for the company, ...

The Japanese launch builds on ClearStrand-ASD’s successful rollout across the United States, where it is now available in 49 states. YAC Bio will partner with hospital systems in Japan to facilitate ...

Brain-computer interfaces (BCIs) are emerging as a groundbreaking technology that has the potential to revolutionize the way humans interact with machines. By bridging the gap between human cognition ...

Texas senators approved several bills Monday, one of which included another attempt at blocking hemp-derived THC products.